139 related articles for article (PubMed ID: 16547342)
1. Bilateral juxtapapillary choroidal neovascularisation associated with interferon alfa treatment of a metastatic cutaneous melanoma.
Garcia-Arumi J; Morral Palau M; Montolio Gil M; Blasco Garrido H; Sararols Ramsay L; Segura García A
Br J Ophthalmol; 2006 Apr; 90(4):516-8. PubMed ID: 16547342
[No Abstract] [Full Text] [Related]
2. Delayed wound healing following treatment with low-dose interferon alfa-2b for cutaneous melanoma.
Ammoury AF; El Sayed F; Bazex J
Arch Dermatol; 2007 Oct; 143(10):1339-40. PubMed ID: 17938359
[No Abstract] [Full Text] [Related]
3. Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma.
Ammoury A; El Sayed F; Farah C; Bazex J
J Am Acad Dermatol; 2008 Mar; 58(3):532-3. PubMed ID: 18280369
[No Abstract] [Full Text] [Related]
4. Lipoatrophy associated with interferon alfa adjuvant therapy for melanoma.
Vallés L; González M; Polo I; Enguita AB; Vanaclocha F; Ortiz-Romero PL
Arch Dermatol; 2009 Jan; 145(1):98-9. PubMed ID: 19153363
[No Abstract] [Full Text] [Related]
5. Lichen planus induced by interferon-alpha-2B therapy in a patient with cutaneous malignant melanoma.
Herrera Saval A; Camacho Martínez F
Acta Derm Venereol; 1999 Sep; 79(5):395. PubMed ID: 10494726
[No Abstract] [Full Text] [Related]
6. Cutaneous sarcoidosis by interferon therapy in a patient with melanoma.
Alonso-Pérez A; Ballestero-Díez M; Fraga J; García-Díez A; Fernández-Herrera J
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1328-9. PubMed ID: 17062055
[No Abstract] [Full Text] [Related]
7. Hypertriglyceridaemia following adjuvant interferon-alpha treatment in two patients with malignant melanoma.
Junghans V; Rünger TM
Br J Dermatol; 1999 Jan; 140(1):183-4. PubMed ID: 10215802
[No Abstract] [Full Text] [Related]
8. Atrophie blanche associated with interferon-alfa adjuvant therapy for melanoma: a cutaneous side effect related to the procoagulant activity of interferon?
Bugatti L; Filosa G; Nicolini M; Filosa A; Verdolini R
Dermatology; 2002; 204(2):154. PubMed ID: 11937746
[No Abstract] [Full Text] [Related]
9. Livedo reticularis associated with interferon alpha therapy in two melanoma patients.
Ruiz-Genao DP; García-F-Villalta MJ; Hernández-Núñez A; Ríos-Buceta L; Fernández-Herrera J; García-Díez A
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):252-4. PubMed ID: 15752306
[TBL] [Abstract][Full Text] [Related]
10. Seizures associated with interferon-alpha treatment of cutaneous malignancies.
Ameen M; Russell-Jones R
Br J Dermatol; 1999 Aug; 141(2):386-7. PubMed ID: 10468841
[No Abstract] [Full Text] [Related]
11. Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?
Radny P; Bauer J; Caroli UM; Eigentler TK; Kamin A; Metzler G; Garbe C
Dermatology; 2004; 209(3):249-50. PubMed ID: 15459547
[No Abstract] [Full Text] [Related]
12. Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma.
Nishihori T; Abdo-Matkiwsky M; Fleishman SB; Blum RH
Am J Clin Oncol; 2005 Oct; 28(5):526. PubMed ID: 16199995
[TBL] [Abstract][Full Text] [Related]
13. Grand mal seizure induced by interferon-alpha-2b.
Kors C; Milling A; Hofmann M; Sterry W; Trefzer U
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):473-4. PubMed ID: 16643159
[No Abstract] [Full Text] [Related]
14. Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma.
Pelletier F; Manzoni P; Jacoulet P; Humbert P; Aubin F
Cutis; 2007 Nov; 80(5):441-5. PubMed ID: 18189032
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous necrosis due to interferon alpha in a patient with melanoma].
Aguilar García G; Serrano Falcón C; Serrano Falcón Mdel M; Carmona MD; Linares Solano J; Serrano Ortega S
Actas Dermosifiliogr; 2006 Oct; 97(8):539-42. PubMed ID: 17067536
[TBL] [Abstract][Full Text] [Related]
16. Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon alpha 2b regimen.
Siegelmann-Danieli N; Bardo M; Law A; Fisk D; Bernath A
Isr Med Assoc J; 2004 Oct; 6(10):636-7. PubMed ID: 15473596
[No Abstract] [Full Text] [Related]
17. Adjuvant interferon therapy and rheumatoid arthritis--a contraindication?
Tsianakas A; Schiller M; Luger TA; Sunderkoetter C
Acta Oncol; 2009; 48(3):468-9. PubMed ID: 18759142
[No Abstract] [Full Text] [Related]
18. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
Hancock BW; Wheatley K; Harris S; Ives N; Harrison G; Horsman JM; Middleton MR; Thatcher N; Lorigan PC; Marsden JR; Burrows L; Gore M
J Clin Oncol; 2004 Jan; 22(1):53-61. PubMed ID: 14665609
[TBL] [Abstract][Full Text] [Related]
19. Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma.
Modjtahedi BS; Maibach H; Park S
Cutan Ocul Toxicol; 2013 Oct; 32(4):341-3. PubMed ID: 23713627
[TBL] [Abstract][Full Text] [Related]
20. Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2.
Ma C; Armstrong AW
J Dermatolog Treat; 2014 Oct; 25(5):401-8. PubMed ID: 23763243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
